Registry of Japanese Patients with Atrial Fibrillation Focused on anticoagulant therapy in New Era:The RAFFINE Study
Not Applicable
Completed
- Conditions
- Atrial Fibrillation
- Registration Number
- JPRN-UMIN000009617
- Lead Sponsor
- Juntendo University School of Medicine Department of Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are hospitalized, anticipated life expectancy less than one year, without consent will be excluded in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie anticoagulant efficacy in Japanese atrial fibrillation patients per RAFFINE study?
How do NOACs (e.g., apixaban, rivaroxaban) compare to VKAs in stroke prevention for Japanese AFib patients in RAFFINE?
Which biomarkers predict anticoagulant response in RAFFINE's Japanese atrial fibrillation cohort?
What adverse event profiles are observed with anticoagulants in RAFFINE's AFib registry?
Are combination therapies with antiplatelets and anticoagulants effective in RAFFINE's AFib patients?